Why the study?
Does ABVD improve complete remission compared to MOPP in patients with advanced Hodgkin's disease?
Population
60 patients with advanced Hodgkin's disease, with no prior chemotherapy; 20% relapsed after primary…
Comparison
ABVD vs MOPP
Design
RCT, Randomized to MOPP vs. ABVD
Authors
Loading...
ABVD matches MOPP for complete remission in advanced Hodgkin lymphoma; confirms effective non-cross-resistant alternative for clinicians and researchers.
Does ABVD improve complete remission compared to MOPP in patients with advanced Hodgkin's disease?
ABVD is an effective alternative to MOPP for inducing complete remission in advanced Hodgkin's disease, with no cross-resistance observed.
Bonadonna et al. (1975) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: